|
1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 4 1.2 List of Figures 4 2 Spain Caprolactam Industry, Supply Scenario, 2000-2016 5 2.1 Spain Caprolactam Industry, Total Plant Capacity, 2000-2016 5 2.2 Spain Caprolactam Industry, Installed Plant Capacity by Key Feedstock, 2011 8 2.3 Spain Caprolactam Industry, Installed Plant Capacity by Production Process, 2011 8 2.4 Spain Caprolactam Industry, Company Share, 2011 8 3 Spain Caprolactam Industry, Market Dynamics, 2000-2016 9 3.1 Spain Caprolactam Industry, Market Size, 2000-2016 9 3.2 Spain Caprolactam Industry, Demand and Production Outlook, 2000-2016 11 3.3 Spain Caprolactam Industry, Demand by End Use Sector, 2011 13 3.4 Spain Caprolactam Industry, Price Forecasts, 2000-2016 14 4 Spain Caprolactam Industry, Trade Balance, 2000-2016 16 4.1 Spain Caprolactam Industry, Imports and Exports, 2000-2016 16 4.2 Spain Caprolactam Industry, Net Exports, 2000-2016 18 4.3 Spain Caprolactam Industry, Imports as Percentage of Demand, 2000-2016 20 5 Ube Industries, Ltd., Company Snapshot 22 5.1 Ube Industries, Ltd., Company Overview 22 5.2 Ube Industries, Ltd., Key Information 22 5.3 Ube Industries, Ltd., Business Description 22 5.3.1 Business Overview 22 5.4 Ube Industries, Ltd., Caprolactam Market, 2011 25 5.4.1 Ube Industries, Ltd., Caprolactam Capacity Split, Spain and Rest of the World, 2011 25 5.4.2 Ube Industries, Ltd., Caprolactam Plant Capacity Share in the Spain, 2011 25 5.4.3 Ube Industries, Ltd., Caprolactam Capacity in the Spain, 2000-2016 25 5.4.4 Ube Industries, Ltd., Caprolactam Plants Details in the Spain, 2011 25 5.5 SWOT Analysis 26 5.5.1 Overview 26 5.5.2 Ube Industries, Ltd. Strengths 26 5.5.3 Ube Industries, Ltd. Weaknesses 28 5.5.4 Ube Industries, Ltd. Opportunities 28 5.5.5 Ube Industries, Ltd. Threats 29 6 Appendix 31 6.1 Definitions 31 6.1.1 Installed Plant Capacity 31 6.1.2 Key Feedstock 31 6.1.3 Process 31 6.1.4 Technology 31 6.2 Abbreviations 31 6.3 GlobalData’s Methodology 31 6.3.1 Coverage 31 6.3.2 Secondary Research 32 6.3.3 Primary Research 32 6.3.4 Expert Panel Validation 33 6.4 Contact Us 33 6.5 Disclaimer 33
|